Lijie Tan

1.6k citations
62 papers · 781 indexed · h-index 15
Topics
Esophageal Cancer Research and Treatment (13 papers)Lung Cancer Diagnosis and Treatment (13 papers)Esophageal and GI Pathology (13 papers)

In The Last Decade

Lijie Tan

54 papers receiving 770 citations

Peers

Lijie Tan
Comparison fields: 5 of 96
  • Pulmonary and Respiratory Medicine 324
  • Surgery 249
  • Molecular Biology 203
  • Cancer Research 139
  • Oncology 134
Replace Muxing Li with:
Muxing Li China
Hai Xu China
Chen Yk Taiwan
Zhaohui He China
Guangyu Luo China
Klaus Martin Germany
Kaiyu Sun China
Jiabin Jin China
Akira Maekawa Japan
Lijie Tan relative to Muxing Li China Muxing Li's profile →
Citations per field
00.5×
Muxing Li · 1×
Citations per year

Countries citing papers authored by Lijie Tan

Since Specialization
Citations

This map shows the geographic impact of Lijie Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijie Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijie Tan more than expected).

Fields of papers citing papers by Lijie Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijie Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijie Tan. The network helps show where Lijie Tan may publish in the future.

Co-authorship network of co-authors of Lijie Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Lijie Tan. A scholar is included among the top collaborators of Lijie Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijie Tan. Lijie Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 3
6 3
7 0
8 6
9 5
10 8
11 7
12 5
13 63
14 19
15 9
16 21
17 0
18 1
19
Evaluation on the Short-term Quality of Life in Patients with Different Gastric Tube Reconstruction after Three-incision Esophagectomy
1
20
The clinical experience of thoracoscopic Heller myotomy for achalasia
1

About Lijie Tan

Lijie Tan is a scholar working on Pulmonary and Respiratory Medicine, Neurology and Surgery, having authored 62 papers that have together received 781 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (13 papers), Lung Cancer Diagnosis and Treatment (13 papers) and Esophageal and GI Pathology (13 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (324 citations), Cancer Research (139 citations) and Neurology (90 citations). Lijie Tan has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Qun Wang, Mingxiang Feng, Yaxing Shen, Cheng Zhan, Tao Lu, Zhencong Chen, Hao Wang, Yong Xi, Jiaqi Liang and Yong Fang. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026